Want to take quizzes and track your credits?
Dramatic reductions in outpatient visits and laboratory testing early in the COVID-19 pandemic1,2 raised concerns about gaps in diabetes management and glycemic control.3 We therefore compared weekly rates of diabetes-related outpatient visits, screening tests, medication fills, and patients’ hemoglobin A1c (HbA1c) levels in 2020 vs 2019 in a national cohort of adults with type 2 diabetes.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: May 5, 2021.
Published Online: July 6, 2021. doi:10.1001/jamainternmed.2021.3047
Corresponding Author: Ateev Mehrotra, MD, MPH, Department of Health Care Policy, Harvard Medical School, 180A Longwood Ave, Boston, MA 02115 (firstname.lastname@example.org).
Author Contributions: Dr Patel had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Patel, Barnett, Mehrotra.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Patel.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Patel, Barnett.
Obtained funding: Mehrotra.
Administrative, technical, or material support: McCoy, Mehrotra.
Conflict of Interest Disclosures: Dr McCoy reported grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) during the conduct of the study; grants from AARP and grants from NIDDK outside the submitted work. Dr Shah reported research support through Mayo Clinic from the US Food and Drug Administration to establish the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); the Centers of Medicare and Medicaid Innovation under the Transforming Clinical Practice Initiative (TCPI); the Agency for Healthcare Research and Quality (R01HS025164; R01HS025402; R03HS025517; K12HS026379); the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R56HL130496; R01HL131535; R01HL151662); the National Science Foundation; from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST) and the Patient Centered Outcomes Research Institute (PCORI) to develop a Clinical Data Research Network (LHSNet). Dr Mehrotra reported grants from Commonwealth Fund during the conduct of the study. No other disclosures were reported.
Funding/Support: This project was supported by the Commonwealth Fund. There was also support from the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK114497; RGM), National Institute on Aging of the National Institutes of Health (K23 AG058806-01; MLB), and National Institute of Mental Health (T32MH019733; SYP).
Role of the Funder/Sponsor: The Commonwealth Fund and the National Institutes of Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank Rebecca Shyu, University of Missouri, for contributing to manuscript preparation efforts. She was not compensated.
You currently have no searches saved.
You currently have no courses saved.